Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Neurology
Disease Category: Amyotrophic Lateral Sclerosis (ALS)

Trial Information

A Multicenter Study for the Validation of ALS Biomarkers

Newsletter/Web Posting

Massachusetts General Hospital is seeking individuals to participate in a specimen collection study enrolling under the direction of Drs. Merit Cudkowicz and Swati Aggarwal.

The purpose of the research study is to collect blood samples from healthy subjects, and both blood and cerebrospinal fluid (CSF) samples from people with amyotrophic lateral sclerosis (ALS), pure lower or upper motor neuron diseases, as well as other neurological diseases that may mimic motor neuron disease. Through comparison of these samples, the researchers hope to learn more about the underlying cause of ALS and find unique biological markers that could help develop new therapies.

Participants must be at least 40 years of age and be able to answer brief questions about their medical and family history, as well as be willing to have blood and/or CSF drawn for the study. If interested, please contact one of our coordinators at 617-726-0563 or e-mail us at mjaffa@partners.org. Interested participants may also contact the Massachusetts General Hospital Neurology Clinical Trials Unit for more information about this study at mghneuroclinicaltrialsunit@partners.org or toll free at 1-877-458-0631.

Matthew Jaffa
Massachusetts General Hospital
55 Fruit Street
Boston, MA 02114
Phone: 617-726-0563
EMail: MJaffa@partners.org

View Google Map

DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.